A $52 million investment fuels Hemispheric, a startup translating brain activity into diagnostic data. The company pairs a proprietary AI model with 15-minute noninvasive scans to identify depression, PTSD, and Parkinson's. This approach bypasses invasive implants. Practitioners can now expect more objective biomarkers for mental health and neurological disorders through rapid, scalable screening.